NCT06613360 Phase 1
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Enrollment
24 pts
Location
United States, Austr...
Sponsor
Cullinan Therapeutics Inc.
NCT05958446
Recruiting
Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women
Enrollment
200 pts
Location
Italy
Sponsor
ASST Fatebenefratelli Sacco